Ahead of ruling that could disrupt access to medication abortion, providers line up alternatives
CBSN
Washington — Abortion providers nationwide are preparing for a ruling from a federal judge in Texas that could disrupt access to a key drug used to facilitate medication abortion, and have been making plans to ensure there is an alternative available for patients if needed.
The forthcoming decision from U.S. District Judge Matthew Kacsmaryk is in response to a request from anti-abortion medical associations to order the Food and Drug Administration (FDA) to withdraw its approval of the drug mifepristone.
Kacsmaryk has scheduled a hearing on Wednesday for the physicians groups and Biden administration to press their arguments about the legality of mifepristone's approval, according to The Washington Post. The Amarillo-based judge could issue a decision after the hearing at any time.

Another winter storm may be headed toward the East Coast of the United States this weekend, on the heels of a powerful and deadly system that blanketed huge swaths of the country in snow and ice. The effects of that original storm have lingered for many areas in its path, and will likely remain as repeated bouts of Arctic air plunge downward from Canada and drive temperatures below freezing. Nikki Nolan contributed to this report. In:

Washington — The Senate is set to take a procedural vote Thursday morning on a package to fund the remaining government agencies and programs, with less than two days to avoid a partial government shutdown. But Democrats say they won't allow the package to move forward without reforms to immigration enforcement. Caitlin Huey-Burns contributed to this report.











